Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma

Philip Jay Bierman, Pierre Giglio

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

The diagnosis of lymphoma of the CNS rests on careful attention to clinical signs and symptoms but has certainly been facilitated by advances in neuroimaging and CSF laboratory analysis. The most common form of CNS involvement in NHL is leptomeningeal disease. Spinal epidural disease may present as an emergency with spinal cord compression, and parenchymal brain metastases may cause seizures, headache, or focal signs and symptoms. After a diagnosis is established, the use of intrathecal or systemic chemotherapy and radiotherapy can improve survival and palliate symptoms. High-dose systemic chemotherapy with hematopoietic stem cell transplantation is an important treatment option at CNS relapse of NHL and for primary CNS lymphoma. An important consideration in this setting is the treatment of CNS disease before transplantation. The prognosis for disease-free survival and cure is much better for patients who have treatment and clearing of the CNS before transplantation than for patients who have active CNS disease at the time of transplant.

Original languageEnglish (US)
Pages (from-to)597-609
Number of pages13
JournalHematology/Oncology Clinics of North America
Volume19
Issue number4
DOIs
StatePublished - Aug 1 2005

Fingerprint

Non-Hodgkin's Lymphoma
Central Nervous System
Central Nervous System Diseases
Signs and Symptoms
Lymphoma
Transplantation
Spinal Diseases
Drug Therapy
Spinal Cord Compression
Hematopoietic Stem Cell Transplantation
Neuroimaging
Disease-Free Survival
Headache
Seizures
Emergencies
Radiotherapy
Therapeutics
Neoplasm Metastasis
Transplants
Recurrence

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma. / Bierman, Philip Jay; Giglio, Pierre.

In: Hematology/Oncology Clinics of North America, Vol. 19, No. 4, 01.08.2005, p. 597-609.

Research output: Contribution to journalReview article

@article{b3943d7ef5cd48bebd7bdad1e8d157d7,
title = "Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma",
abstract = "The diagnosis of lymphoma of the CNS rests on careful attention to clinical signs and symptoms but has certainly been facilitated by advances in neuroimaging and CSF laboratory analysis. The most common form of CNS involvement in NHL is leptomeningeal disease. Spinal epidural disease may present as an emergency with spinal cord compression, and parenchymal brain metastases may cause seizures, headache, or focal signs and symptoms. After a diagnosis is established, the use of intrathecal or systemic chemotherapy and radiotherapy can improve survival and palliate symptoms. High-dose systemic chemotherapy with hematopoietic stem cell transplantation is an important treatment option at CNS relapse of NHL and for primary CNS lymphoma. An important consideration in this setting is the treatment of CNS disease before transplantation. The prognosis for disease-free survival and cure is much better for patients who have treatment and clearing of the CNS before transplantation than for patients who have active CNS disease at the time of transplant.",
author = "Bierman, {Philip Jay} and Pierre Giglio",
year = "2005",
month = "8",
day = "1",
doi = "10.1016/j.hoc.2005.05.003",
language = "English (US)",
volume = "19",
pages = "597--609",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma

AU - Bierman, Philip Jay

AU - Giglio, Pierre

PY - 2005/8/1

Y1 - 2005/8/1

N2 - The diagnosis of lymphoma of the CNS rests on careful attention to clinical signs and symptoms but has certainly been facilitated by advances in neuroimaging and CSF laboratory analysis. The most common form of CNS involvement in NHL is leptomeningeal disease. Spinal epidural disease may present as an emergency with spinal cord compression, and parenchymal brain metastases may cause seizures, headache, or focal signs and symptoms. After a diagnosis is established, the use of intrathecal or systemic chemotherapy and radiotherapy can improve survival and palliate symptoms. High-dose systemic chemotherapy with hematopoietic stem cell transplantation is an important treatment option at CNS relapse of NHL and for primary CNS lymphoma. An important consideration in this setting is the treatment of CNS disease before transplantation. The prognosis for disease-free survival and cure is much better for patients who have treatment and clearing of the CNS before transplantation than for patients who have active CNS disease at the time of transplant.

AB - The diagnosis of lymphoma of the CNS rests on careful attention to clinical signs and symptoms but has certainly been facilitated by advances in neuroimaging and CSF laboratory analysis. The most common form of CNS involvement in NHL is leptomeningeal disease. Spinal epidural disease may present as an emergency with spinal cord compression, and parenchymal brain metastases may cause seizures, headache, or focal signs and symptoms. After a diagnosis is established, the use of intrathecal or systemic chemotherapy and radiotherapy can improve survival and palliate symptoms. High-dose systemic chemotherapy with hematopoietic stem cell transplantation is an important treatment option at CNS relapse of NHL and for primary CNS lymphoma. An important consideration in this setting is the treatment of CNS disease before transplantation. The prognosis for disease-free survival and cure is much better for patients who have treatment and clearing of the CNS before transplantation than for patients who have active CNS disease at the time of transplant.

UR - http://www.scopus.com/inward/record.url?scp=23244455813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244455813&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2005.05.003

DO - 10.1016/j.hoc.2005.05.003

M3 - Review article

C2 - 16083825

AN - SCOPUS:23244455813

VL - 19

SP - 597

EP - 609

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 4

ER -